On the occasion of the live broadcast of the BFM Business Grand Prix for Intermediate-Sized Enterprises on the evening of September 11, and in partnership with Banque Palatine, UPSA was awarded the 2023 prize in the “Made in France” category. This award, which honors intermediate-sized companies with recognized French expertise, is a tribute to the daily work of UPSA’s 1,700 employees—particularly the 1,500 based in Agen, who have been true specialists in the production of paracetamol-based medicines for 87 years.
According to Laure Lechertier, Director of Internal and External Affairs and CSR at UPSA: “We are deeply honored that our daily commitment to manufacturing our medicines at our two production sites in Agen has been recognized. From the beginning, we have chosen to produce in France, which allows us to remain agile and ensure the availability of essential medicines for the health of the French population.”